Evidence map›Paper›PMID 42223553›Full record

ReviewCurrent HIV/AIDS reports2026

Central Nervous System HIV Persistence and Clinical Consequences During Suppressive ART.

Kathryn B Holroyd, Serena Spudich, Alan Winston, Sam Nightingale

Abstract readReview
PubMed Publisher
In one paragraph

Review in Current HIV/AIDS reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Kathryn B HolroydDepartment of Neurology, Columbia University, 710 West 168th Street, New York, NY, 10032, US. Kh3311@cumc.columbia.edu.
Serena SpudichDepartment of Neurology, Yale University, New Haven, CT, US.
Alan WinstonDepartment of Infectious Disease, Faculty of Medicine, Imperial College, London, UK.
Sam NightingaleDepartment of Infectious Disease, Faculty of Medicine, Imperial College, London, UK.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purpose of reviewThis review discusses recent advances in understanding the mechanisms of CNS HIV invasion and persistence and examines how these processes relate to the neurologic complications of HIV. RECENT

findingsRecent studies have provided compelling evidence that HIV can persist within CNS macrophages and microglia despite long-term suppressive ART, supporting the existence of a CNS reservoir. Updates to treatment of neurosymptomatic CSF HIV RNA escape include evaluation of CNS-specific drug resistance patterns and ART optimization. Evaluation of cognitive symtpoms in persons with HIV should include a comprehensive medical and neurologic evaluation, cessation of Efavirenz, and evaluation of HIV disease activity and immune dysregulation. Novel HIV cure strategies, including shock-and-kill approaches, block-and-lock strategies, and broadly neutralizing antibodies have highlighted the importance of understanding CNS reservoir dynamics and potential neurotoxicity when designing HIV cure strategies. HIV enters the CNS during early infection and may establish a persistent viral reservoir. CNS HIV persistence has important clinical implications, including symptomatic CSF HIV RNA escape and cognitive dysfunction, and may represent a barrier to HIV cure.

Indexed as

Anti-HIV AgentsCentral Nervous SystemHIV-1HIV InfectionsHumansRNA, ViralAnti-HIV AgentsRNA, ViralCognitive impairmentHIV CNS persistenceHIV cureHIV RNA escape

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.